BioTech 365

MAY 7, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gene therapy biotech Gyroscope finds unnavigable seas on IPO market.Gene therapy biotech Gyroscope finds unnavigable seas on IPO market aarmstrong Fri, 05/07/2021 – 09:50 from FierceBiotech: Biotech … Continue reading (..)

Gene Therapy 40

Gene Therapy Gene Marketing Research 40

BioTech 365

APRIL 23, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Replimune, prepping for market, taps Genentech oncology vet as CMO.Chutes & Ladders—Replimune, prepping for market, taps Genentech oncology vet as CMO fkansteiner Thu, 04/22/2021 – … Continue (..)

Marketing 40

Marketing Research 40

BioTech 365

FEBRUARY 1, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Targeting a rapid market breakthrough for new vaccine production method.In

Production 40

Production Vaccination Vaccine Marketing 40

BioTech 365

MAY 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Aceragen bags Enzyvant drug and $35M, plots fast path to market.Aceragen bags Enzyvant drug and $35M, plots fast path to market ntaylor Mon, 05/03/2021 – 07:56 from … Continue reading →

Marketing 40

Marketing Drugs Research 40

BioTech 365

APRIL 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bannister joins SVB to help companies raise cash, access public markets.Bannister joins SVB to help companies raise cash, access public markets ntaylor Thu, 04/08/2021 – 08:17 from … Continue reading →

Marketing 40

Marketing Research 40

BioSpace

DECEMBER 5, 2021

The regulatory agency just placed new safety warnings on that drug class, which will impact AbbVie's Rinvoq (upadacitinib), a drug the company has seen as a successor to its revenue-driving Humira.

Marketing 88

Marketing Drugs 88

BioTech 365

APRIL 9, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Werewolf Therapeutics looks to make a killing in the public markets with a $100M IPO.Werewolf Therapeutics looks to make a killing in the public markets with a … Continue reading →

Marketing 40

Marketing Research 40

BioTech 365

APRIL 26, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca and Sanofi’s antibody prevents RSV in phase 3, accelerating path to market.AstraZeneca and Sanofi’s antibody prevents RSV in phase 3, accelerating path to market ntaylor Mon, … Continue reading → (..)

Antibody 40

Antibody Marketing Research 40

BioTech 365

MAY 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Avrobio plans head-to-head Fabrazyme trial after FDA changes path to market.Avrobio plans head-to-head Fabrazyme trial after FDA changes path to market ntaylor Mon, 05/03/2021 – 08:41 from … Continue reading → (..)

Trials 40

Trials Marketing Research 40

BioTech 365

MAY 12, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Amgen, AstraZeneca’s tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi’s Dupixent.Amgen, AstraZeneca’s tezepelumab is looking for a slice of blockbuster asthma market … (..)

Marketing 40

Marketing Research 40

BioTech 365

SEPTEMBER 8, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CRO market to recover, using ‘hybrid trials,’ with revenue hitting $64B by 2024: report.CRO market to recover, using ‘hybrid trials,’ with revenue hitting $64B by 2024: report … Continue reading → (..)

Marketing 40

Marketing Trials Research 40

BioTech 365

OCTOBER 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Dicerna narrows focus for kidney drug after mixed data, setting up head-to-head market battle with rival Alnylam.Dicerna narrows focus for kidney drug after mixed data, setting up … Continue reading →

Marketing 40

Marketing Drugs Research 40

BioTech 365

SEPTEMBER 25, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Looking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO.Looking for an edge in the wet AMD market, phase 3 … Continue reading →

Marketing 40

Marketing Research 40

Outsourcing Pharma

JANUARY 30, 2024

With colorectal cancer (MRC) being the second biggest cancer type in Hong Kong, it is positive news that Hutchmed has received marketing approval for its Elunate (fruquintinib) small molecule treatment.

Marketing 92

Marketing Clinical Development Development 92

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. While bear markets and financial volatility are not new in biotech, rising interest rates, growing inflation, and the war in Ukraine have all fueled uncertainty in recent times.

Marketing 324

Marketing Gene Therapy Manufacturing Pharma Companies 324

Intouch Solutions

MARCH 15, 2024

In a recent article published by Med Ad News and PharmaLive.com , Hattie Stearns, Senior Director of Experience DesignOps, provides five key takeaways she observed as a brand and design lead at SXSW 2024.

Branding 103

Branding Marketing Production 103

Pharmaceutical Commerce

APRIL 2, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Marketing 52

Marketing 52

Pharmaceutical Commerce

FEBRUARY 4, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Marketing 69

Marketing Drugs 69

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. While bear markets and financial volatility are not new in biotech, rising interest rates, growing inflation, and the war in Ukraine have all fueled uncertainty in recent times.

Marketing 162

Marketing Gene Therapy Manufacturing Pharma Companies 162

World of DTC Marketing

AUGUST 9, 2021

86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. Most HCPs go to Medscape as a “first stop” in the morning to get their healthcare news. Doximity was flagged for having anti-vaccine information.

Nurses 294

Nurses Marketing Pharma Companies Production 294

Fierce Pharma

MARCH 28, 2024

After news broke earlier this month that Danish antibody specialist Genmab would receive up to $8.4 million in state tax credits as part of a plan to grow its presence in Plainsboro, New Jersey, re | Genmab has snared a lease to upsize its U.S.

Antibody 70

Antibody Marketing 70

Intouch Solutions

OCTOBER 20, 2023

This year’s Dreamforce conference – the annual gathering for Salesforce, one of the main providers in commercial marketing and sales technology for the Health & Life Science (HLS) industry – was bigger and more innovative than ever. But what news will matter most for health & life sciences companies?

Life Science 105

Life Science Marketing Sales 105

Intouch Solutions

AUGUST 25, 2023

” In a recent article for PharmaLive.com and Med Ad News, Elizabeth Rooney, Managing Director, Executive Creative Director, EVERSANA INTOUCH urges all healthcare marketers to make the most of this moment in the cultural zeitgeist to make a difference for women’s health. ” she says.

Sales 98

Sales Marketing 98

Outsourcing Pharma

JANUARY 30, 2024

With colorectal cancer (MRC) being the second biggest cancer type in Hong Kong, it is positive news that Hutchmed has received marketing approval for its Elunate (fruquintinib) small molecule treatment.

Marketing 52

Marketing Clinical Development Development 52

Pharmaceutical Commerce

JANUARY 23, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Manufacturing 52

Manufacturing Marketing 52

Pharmaceutical Technology

MARCH 31, 2023

Available to people ages 16 years and above who have been vaccinated with a Covid-19 mRNA vaccine, EMA’s Human Medicines Committee concluded the vaccine is ready for marketing authorization in the EU, on 30 March. Bimervax is a recombinant protein subunit vaccine, marketed by the Girona, Spain-based Hipra.

Vaccination 277

Vaccination Vaccine Immune Response Antibody 277

World of DTC Marketing

NOVEMBER 10, 2020

SUMMARY : Pfizer’s 90 percent effectiveness is very impressive, but the rate is based on a relatively small number of people and the data has not been peer-reviewed but today headlines rule the news, not content. Pfizer’s results are promising and are coming at a time when the world is anxiously awaiting positive news.

Vaccination 286

Vaccination Vaccine Marketing Drugs 286

World of DTC Marketing

FEBRUARY 7, 2022

According to Endpoint News” We’ve seen Biogen’s CSO exit under pressure in recent weeks, and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Click to Tweet.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

Fierce Pharma

NOVEMBER 30, 2023

we're highlighting two weeks' worth of biopharma news related to Asia. market at a 20% discount to Merck's Keytruda. Because of the recent Thanksgiving holiday in the U.S., AstraZeneca in-licensed a KRAS G12D inhibitor from China's Usynova. BeiGene bought global rights to a CDK2 inhibitor in a deal worth up to $1.3

Licensing 81

Licensing Licensing Marketing 81

Drug Channels

JANUARY 4, 2024

Paula and I have some exciting news to share with you: Drug Channels Institute is joining the HMP Global family! HMP is a leading omnichannel healthcare education, events, and market insights company. It’s a great fit for DCI.

Drugs 76

Drugs Marketing 76

XTalks

NOVEMBER 15, 2023

Starry soda, Pepsi’s innovative entry in the lemon-lime soda market, has nearly completed its first year on the market. Introduced in January 2023, this strategic move was aimed at competing with Sprite, Coca-Cola’s dominant lemon-lime beverage, which boasts a seven percent share in the $82 billion US soda market.

Marketing 104

Marketing Branding Production 104

Pharmaceutical Technology

NOVEMBER 14, 2022

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Oncopeptides’ Pepaxti (melphalan flufenamide; melflufen) along with dexamethasone to treat multiple myeloma patients. Currently, the company is analysing Pepaxti’s market access options in the country.

Marketing 130

Marketing Drugs Clinical Trials Clinical Trials 130

XTalks

DECEMBER 19, 2023

As we reflect on this dynamic year, it’s exciting to revisit the food news of 2023 that captivated our readers’ imaginations and sparked the most discussions. It’s a tale of innovation, consumer preferences and the challenges of introducing alternative sweeteners to a market dominated by traditional tastes.

Branding 98

Branding Packaging Packaging Production 98

World of DTC Marketing

NOVEMBER 11, 2020

Still, DTC marketers should be aware of what’s being said around certain health conditions via social media. The top 50 articles garnered more than 12 million shares, comments, and reactions this year, mostly on Facebook” Despite the rise in online health seekers, pharma is not part of the solution to combat fake health news.

Marketing 195

Marketing Pharma Companies Sales Drugs 195

Pharmaceutical Technology

JANUARY 27, 2023

The FDA’s recent approval of TG Therapeutics’s Briumvi (ublituximab) against relapsing forms of multiple sclerosis (MS) is welcome news for the company after suffering a major setback in 2022 when the FDA extended its review of Briumvi by three months. Some 48% of patients on Briumvi also suffered with infusion reactions.

Marketing 130

Marketing Antibody Clinical Trials Clinical Trials 130

Camargo

JUNE 4, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. patients undergoing such surgeries today receive an opioid, and given the increasing number of opioid-related deaths, this approval is indeed good news.

Development 130

Development Production Drugs Marketing 130

STAT News

OCTOBER 10, 2022

The news comes about a year after another large oncology provider chain hit the stock market. Florida-based American Oncology Network, a company with more than 100 affiliated doctors across 18 states, announced last week it plans to go public. Its shares have since lost roughly half their value. 

Doctors 105

Doctors Doctor Marketing 105